Morich Frank
SEC insider (Form 3/4/5 filer). CIK 0001748615. Director at Perspective Therapeutics, Inc. (CATX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in SEATTLE, WA.
Companies Morich Frank has filed insider reports for
- Perspective Therapeutics, Inc. (CATX): Director
- Cue Biopharma, Inc. (CUE): Director
Morich Frank
CIK: 0001748615
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 2, 2026CATX
Perspective Therapeutics, Inc.
AwardDirectStock option (right to buy)
50K shares- - Jan 2, 2026CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
24.4K shares- - Mar 3, 2025CATX
Perspective Therapeutics, Inc.
AwardDirectStock option (right to buy)
50K shares- - Jan 2, 2025CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
24.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 |  CATX Perspective Therapeutics, Inc. | Award Stock option (right to buy) | 50,000 | - | - | Direct |
| Jan 2, 2026 |  CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 24,400 | - | - | Direct |
| Mar 3, 2025 | CATX Perspective Therapeutics, Inc. | Award Stock option (right to buy) | 50,000 | - | - | Direct |
| Jan 2, 2025 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 24,400 | - | - | Direct |
1-4 of 4 transactions